Form 8-K - Current report:
SEC Accession No. 0001708599-25-000042
Filing Date
2025-04-14
Accepted
2025-04-14 16:28:04
Documents
19
Period of Report
2025-04-08
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ser-20250408.htm   iXBRL 8-K 41957
2 EX-3.1 ex31_certificateofdesignat.htm EX-3.1 110988
3 EX-10.1 ex101_pipesecuritiespurcha.htm EX-10.1 83453
4 EX-99.1 ser-20250408xex991pronpipe.htm EX-99.1 11239
8 image_0.jpg GRAPHIC 143
9 image_0a.jpg GRAPHIC 138
10 serina.jpg GRAPHIC 25652
  Complete submission text file 0001708599-25-000042.txt   535858

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ser-20250408.xsd EX-101.SCH 1800
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ser-20250408_lab.xml EX-101.LAB 54435
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ser-20250408_pre.xml EX-101.PRE 31811
21 EXTRACTED XBRL INSTANCE DOCUMENT ser-20250408_htm.xml XML 2920
Mailing Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806
Business Address 601 GENOME WAY SUITE 2001 HUNTSVILLE AL 35806 (256) 327-9630
Serina Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

EIN.: 821436829 | State of Incorp.: AL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38519 | Film No.: 25836346
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)